Target Name: Casein Kinase I gamma
NCBI ID: P13001
Review Report on Casein Kinase I gamma Target / Biomarker Content of Review Report on Casein Kinase I gamma Target / Biomarker
Casein Kinase I gamma
Other Name(s): None

CK-I Gamma Protein: Potential Drug Targets Or Biomarkers

Casein Kinase I gamma (CK-纬) is a protein that is expressed in a variety of tissues throughout the body. It is a key regulator of protein-protein interactions and has been implicated in a number of cellular processes, including cell signaling, DNA replication, and stress response. In recent years, researchers have become interested in using CK-纬 as a drug target or biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

CK-纬 is a member of the Casein Kinase family, which includes a number of different proteins that play important roles in cellular signaling. These proteins are characterized by a catalytic core that consists of a protein kinase domain, a nucleotide-binding oligomerization domain ( N-terminal domain), and a carboxy-terminal domain. The N-terminal domain is responsible for activating the protein kinase domain, while the C-terminal domain is responsible for the stability and localization of the protein.

CK-纬 is a 21-kDa protein that is expressed in a variety of tissues throughout the body, including muscle, heart, liver, kidney, and brain. It is highly conserved, with a high degree of sequence identity between different isoforms. The CK-纬 gene is located on chromosome 11q22 and has been implicated in a number of cellular processes.

One of the key functions of CK-纬 is its role in protein-protein interaction. It is a highly conserved protein that is involved in the regulation of a wide variety of protein interactions, including the interaction between adapter proteins and their target proteins. CK -纬 has been shown to play a key role in the regulation of the activity of the protein tyrosine phosphatase (PTP) enzyme, which is involved in the regulation of many cellular processes, including cell signaling, DNA replication, and stress response.

In addition to its role in protein-protein interaction, CK-纬 is also involved in the regulation of DNA replication and stress response. It has been shown to play a key role in the regulation of DNA replication, both in the absence of DNA replication factors and in the presence of DNA replication factors. CK-纬 has also been shown to play a role in the regulation of stress response, by activating the stress-responsive protein heat shock protein (Hsp70) in response to stress.

Given its involvement in a wide variety of cellular processes, CK-纬 has been identified as a potential drug target or biomarker for a variety of diseases. For example, CK-纬 has been shown to be highly expressed in a variety of cancer tissues and has been implicated in the regulation of cancer cell growth, invasion, and metastasis. In addition, CK-纬 has also been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

Another potential application of CK-纬 as a drug target or biomarker is its role in the regulation of autoimmune disorders. CK-纬 has been shown to play a key role in the regulation of immune cell function, including the regulation of T cell activity and the regulation of inflammation. In addition, CK-纬 has also been implicated in the regulation of inflammation in general, by activating the transcription factor nuclear factor kappa B (NF-kappa-B) in response to inflammation.

In conclusion, CK-纬 is a highly conserved protein that is involved in a wide variety of cellular processes. It has been implicated in the regulation of protein-protein interaction, DNA replication, and stress response, as well as the regulation of cancer, neurodegenerative diseases, and autoimmune disorders. As a result, CK-纬 has emerged as a promising drug target or biomarker for a variety of diseases. Further research is needed to fully understand the role of CK-纬 in

Protein Name: Casein Kinase I Gamma (nonspecified Subtype)

The "Casein Kinase I gamma Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Casein Kinase I gamma comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

Casein kinase II (CKII) | CASK | CASKIN1 | CASKIN2 | CASKP1 | CASP1 | CASP10 | CASP12 | CASP14 | CASP16P | CASP1P2 | CASP2 | CASP3 | CASP4 | CASP4LP | CASP5 | CASP6 | CASP7 | CASP8 | CASP8AP2 | CASP9 | Caspase | CASQ1 | CASQ2 | CASR | CASS4 | CAST | CASTOR1 | CASTOR2 | CASTOR3P | CASZ1 | CAT | Cathepsin | CATIP | CATIP-AS1 | CATSPER1 | CATSPER2 | CATSPER2P1 | CATSPER3 | CATSPER4 | CATSPERB | CATSPERD | CATSPERE | CATSPERG | CATSPERZ | CAV1 | CAV2 | CAV3 | CAVIN1 | CAVIN2 | CAVIN3 | CAVIN4 | CBARP | CBFA2T2 | CBFA2T3 | CBFA2T3-ZNF651 corepressor complex | CBFB | CBL | CBLB | CBLC | CBLIF | CBLL1 | CBLL1P1 | CBLL2 | CBLN1 | CBLN2 | CBLN3 | CBLN4 | CBR1 | CBR1-AS1 | CBR3 | CBR3-AS1 | CBR4 | CBS | CBWD7 | CBX1 | CBX1P1 | CBX2 | CBX3 | CBX3P2 | CBX3P5 | CBX4 | CBX5 | CBX6 | CBX7 | CBX8 | CBY1 | CBY2 | CBY3 | CC2D1A | CC2D1B | CC2D2A | CC2D2B | CCAR1 | CCAR2 | CCAT1 | CCAT2 | CCBE1 | CCDC102A | CCDC102B